Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Jeanny B Aragon-Ching

A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation.

scientific article

A phase II clinical trial of sorafenib in androgen-independent prostate cancer

scientific article published in January 2008

A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia

scientific article published on 18 May 2015

About tyrosine kinase inhibitors (TKIs) in prostate cancer: where do we go from here?

scientific article published on 10 November 2009

Active surveillance for prostate cancer: has the time finally come?

scientific article

Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab

article

Advanced prostate cancer - patient survival and potential impact of enzalutamide and other emerging therapies

scientific article

Advances in systemic therapies for metastatic castration-resistant prostate cancer

scientific article

American Cancer Society prostate cancer survivorship care guidelines.

scientific article

Angiogenesis inhibition in prostate cancer: current uses and future promises.

scientific article

Angiogenesis inhibitors in prostate cancer therapy.

scientific article published on December 2010

Anti-angiogenesis approach to genitourinary cancer treatment.

scientific article published on January 2009

Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS metastases: the Road less Travelled

scientific article published on 08 January 2013

Bone-targeted therapies in metastatic castration-resistant prostate cancer: evolving paradigms.

scientific article published on 28 August 2013

Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data

scientific article published on 19 July 2019

Cardiovascular disease with androgen deprivation: the (forgotten) role of testosterone

scientific article published on 2 November 2009

Challenges and advances in the diagnosis, biology, and treatment of urothelial upper tract and bladder carcinomas.

scientific article

Characterization of Differences Between Prostate Cancer Patients Presenting With De Novo Versus Primary Progressive Metastatic Disease

scientific article published on 31 August 2017

Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression?

scientific article

Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer

scientific article published on 18 April 2015

Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

scientific article published in February 2017

Complete response to EPOCH in a patient with HIV and extracavitary primary effusion lymphoma involving the colon: a case report and review of literature

scientific article published on 20 January 2012

Cytotoxic compounds in the treatment of castration-resistant prostate cancer.

scientific article published on December 2009

Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial

scientific article

Drug therapies for metastatic castration-resistant prostate cancer

scientific article published on 14 August 2015

Editorial [Hot Topic: Multidrug Resistance: Genes, Polymorphisms, Biologic Effects, Reversal and Treatment in Cancer Chemotherapy (Guest Editor: Jeanny B. Aragon-Ching)]

article

Editorial [Hot topic: Prostate Cancer Therapy (Guest Editors: N. Sharifi and J.B. Aragon-Ching)]

scientific article published on 01 December 2009

Enzalutamide (formerly MDV3100) as a new therapeutic option for men with metastatic castration-resistant prostate cancer ⬇️

scientific article published on 08 October 2012

Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer

scientific article published on 01 March 2019

Epithelioid Angiosarcoma of the Bladder: A Case Report and Review of the Literature

scientific article published on 23 July 2018

Erratum for "metastatic castration-resistant prostate cancer: critical review of enzalutamide"

scientific article published on 27 November 2013

Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.

scientific article

From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer ⬇️

scientific article published on June 1, 2011

Frontline immunotherapy treatment with nivolumab and ipilimumab in metastatic renal cell cancer: a new standard of care

scientific article published on 17 October 2018

Further analysis of PREVAIL: enzalutamide use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer

scientific article published on November 2014

Further analysis of the survival benefit of clodronate

scientific article published on 30 December 2009

Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.

scientific article published on February 2009

Hematuria in sickle cell trait: the importance of ruling out occult cancer

scientific article published on 09 April 2011

Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.

scientific article published on February 2009

Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives

scientific article published on 11 July 2017

Implications for chemoprevention of prostate cancer with intake of cruciferous vegetables

scientific article published on 18 April 2011

Ipilimumab: a potential immunologic agent in the treatment of metastatic castration-resistant prostate cancer

scientific article published on 21 July 2014

Is There an Optimal Treatment Sequencing Strategy for Metastatic Castration-Resistant Prostate Cancer? ⬇️

scientific article published on May 1, 2013

Key Difficulties Associated with Cancer Biology

scientific article published on 15 November 2016

Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer.

scientific article published on 16 August 2008

Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancer

article

Life under the CABOSUN: Cabozantinib improves quality-adjusted survival in comparison with sunitinib

scientific article published on 06 October 2020

Maintenance avelumab for metastatic urothelial cancer: a new standard of care

scientific article published on 18 November 2020

Mechanisms of drug resistance to vascular endothelial growth factor (VEGF) inhibitors

scientific article published on October 2010

Metastatic castration-resistant prostate cancer: critical review of enzalutamide.

scientific article

Mucinous Signet-Ring Urachal Carcinoma of the Bladder: Case Report and Review of the Literature.

scientific article published on 10 May 2017

Mucosa-associated lymphoma tissue of the dura presenting as meningioma

scientific article

Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions

scientific article published on 01 May 2018

Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Are We Asking the Right Questions?

scientific article published on 10 November 2014

Osteonecrosis of the Jaw and the Use of Antiangiogenic Agents: Just an Association?

scientific article published on 16 December 2008

Phase I study of oral lenalidomide in patients with refractory metastatic cancer

scientific article

Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity ⬇️

scientific article published on May 17, 2013

Positron emission tomography findings in clinical mimics of lymphoma

scientific article published on June 2011

Primary diffuse large B-cell lymphoma of the ureter in a patient with HIV: a case report and review of literature

scientific article published on 03 January 2013

Promises and Pitfalls of Primary Local Treatment in Metastatic Prostate Cancer

scientific article published on 12 December 2016

Radium-223 for the treatment of castration-resistant prostate cancer.

scientific article published on 18 May 2015

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

scientific article published on 18 November 2019

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer

scientific article

Role of chemotherapy in prostate cancer.

scientific article published on 20 October 2017

Systemic therapy in muscle-invasive and metastatic bladder cancer: current trends and future promises

scientific article published on 16 June 2016

Targeted therapies in the treatment of urothelial cancers

scientific article published on 30 March 2017

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer

scientific article

Targeting the androgen receptor in metastatic castration-resistant prostate cancer

scientific article published in February 2014

Thalidomide analogues as anticancer drugs

scientific article

The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate Cancer

scientific article published on 07 March 2019

The Utility of Chemotherapy in the Treatment of Metastatic Prostate Cancer

scientific article published on 11 December 2013

The changing landscape in the treatment of metastatic castration-resistant prostate cancer ⬇️

scientific article published on January 1, 2013

The evolution of prostate cancer therapy: targeting the androgen receptor

scientific article

The immunotherapy revolution in genitourinary malignancies

scientific article published on 29 June 2020

The path forward in prostate cancer therapeutics.

scientific article published in May 2018

The promising role of nivolumab in renal cell cancers

scientific article published on 21 January 2016

The promising role of poly(ADP-ribose) polymerase inhibitors in prostate cancer

scientific article published on 19 February 2016

The role of angiogenesis inhibitors in prostate cancer.

scientific article published on January 2008

The use of 5-alpha reductase inhibitors for the prevention of prostate cancer

scientific article published on 13 July 2010

Treatment in hormone-sensitive metastatic prostate cancer: factors to consider when personalizing therapy

scientific article published on 14 May 2020

Treatment of Adult Soft Tissue Sarcoma: Old Concepts, New Insights, and Potential for Drug Discovery ⬇️

scientific article published on 05 April 2012

Unravelling the role of denosumab in prostate cancer

scientific article published in The Lancet

Use of denosumab for renal cell carcinoma-associated malignant hypercalcemia: a case report and review of the literature

scientific article published on 02 September 2013

Use of early chemotherapy for hormone-sensitive prostate cancer: time for CHAARTED.

scientific article

VEGF inhibitors and prostate cancer therapy

scientific article published on June 2009

Vitamin D in prostate cancer.

scientific article

Zoledronic acid for the treatment of prostate cancer

scientific article published on 07 February 2019

Paulina is supported by:

About Paulina

Help